期刊
INTERNATIONAL JOURNAL OF OBESITY
卷 35, 期 2, 页码 153-166出版社
SPRINGERNATURE
DOI: 10.1038/ijo.2010.132
关键词
brain; hormone; RYGB; ghrelin; GLP-1; PYY
The rising prevalence of obesity has reached pandemic proportions, with an associated cost estimated at up to 7% of health expenditures worldwide. Bariatric surgery is currently the only effective long-term treatment for obesity and obesity-related co-morbidities in clinically severely obese patients. However, the precise physiological mechanisms underlying the postsurgical reductions in caloric intake and body weight are poorly comprehended. It has been suggested that changes in hormones involved in hunger, food intake and satiety via the neurohormonal network may contribute to the efficacy of bariatric procedures. In this review, we consider how gastrointestinal hormone concentrations, involved in appetite and body weight regulation via the gut-brain axis, are altered by different bariatric procedures. Special emphasis is placed on neurohormonal changes following Roux-en-Y gastric bypass surgery, which is the most common and effective procedure used today. International Journal of Obesity (2011) 35, 153-166; doi: 10.1038/ijo.2010.132; published online 13 July 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据